Cita APA (7a ed.)

Thura, M., Al-Aidaroos, A. Q., Gupta, A., Chee, C. E., Lee, S. C., Hui, K. M., . . . Zeng, Q. (2019). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Portfolio.

Cita Chicago Style (17a ed.)

Thura, Min, et al. PRL3-zumab as an Immunotherapy to Inhibit Tumors Expressing PRL3 Oncoprotein. Nature Portfolio, 2019.

Cita MLA (8a ed.)

Thura, Min, et al. PRL3-zumab as an Immunotherapy to Inhibit Tumors Expressing PRL3 Oncoprotein. Nature Portfolio, 2019.